Search Results - "TIBBITTS, J"
-
1
Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions
Published in Scientific reports (06-12-2017)“…Engagement of Fcγ-receptors triggers a range of downstream signalling events resulting in a diverse array of immune functions. As a result, blockade of…”
Get full text
Journal Article -
2
Semi-mechanistic Population Pharmacokinetic Model of Multivalent Trastuzumab Emtansine in Patients with Metastatic Breast Cancer
Published in Clinical pharmacology and therapeutics (01-10-2012)“…Trastuzumab emtansine (T‐DM1) is an antibody–drug conjugate (ADC) composed of multiple molecules of the antimicrotubule agent DM1 linked to trastuzumab, a…”
Get full text
Journal Article -
3
Attenuated Salmonella enterica Serovar Typhi Expressing Urease Effectively Immunizes Mice against Helicobacter pylori Challenge as Part of a Heterologous Mucosal Priming-Parenteral Boosting Vaccination Regimen
Published in Infection and Immunity (01-09-2002)“…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
4
Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection
Published in Infection and immunity (01-06-1998)“…To determine the optimal inductive sites for immunization against Helicobacter pylori infection, the protective efficacy of recombinant urease (rUre) was…”
Get full text
Journal Article -
5
Vulnerability of mouse cortical neurons to doxorubicin-induced apoptosis is strain-dependent and is correlated with mRNAs encoding Fas, Fas-Ligand, and metalloproteinases
Published in Apoptosis (London) (01-09-2004)“…Cell surface death receptor-mediated neuronal apoptosis, which is a critical component of neurodegeneration, is modulated by matrix metalloproteinases (MMPs)…”
Get full text
Journal Article -
6
-
7
Sterilizing immunity against experimental Helicobacter pylori infection is challenge-strain dependent
Published in Vaccine (14-09-2001)“…The development of a murine model of Helicobacter pylori infection through serial in vivo passage of candidate strains has enabled a quantitative assessment of…”
Get full text
Journal Article -
8
-
9
-
10
Risk of Helicobacter pylori infection among long-term residents in developing countries
Published in The American journal of tropical medicine and hygiene (01-02-1999)“…The seroprevalence and incidence of Helicobacter pylori infection were determined among 312 North American missionaries who were serving in developing…”
Get more information
Journal Article -
11
P016 SZN-1326, a Wnt signal activator, is more efficacious than cyclosporine A in an acute DSS model
Published in Journal of Crohn's and colitis (27-05-2021)“…Abstract Background Current Inflammatory bowel disease (IBD) treatments focus on inhibition of excessive inflammation, and clinical remission rates have…”
Get full text
Journal Article -
12
P023 SZN-1326, a Wnt agonist, improved epithelial healing and ameliorated colitis in a chronic DSS model, in stark contrast to anti-TNF and anti-IL-12/23p40 antibodies
Published in Journal of Crohn's and colitis (27-05-2021)“…Abstract Background All currently approved treatments for Inflammatory bowel disease (IBD) and the majority of drugs in the pipeline are anti-inflammatory…”
Get full text
Journal Article -
13
Issues related to the use of canines in toxicologic pathology: Issues with pharmacokinetics and metabolism
Published in Toxicologic pathology (01-01-2003)“…The dog is a commonly used animal model by virtue of its size, well-characterized physiology, and ease of handling. For these reasons and others, dogs are also…”
Get full text
Conference Proceeding Journal Article -
14
-
15
A phase I study of weekly dosing of trastuzumab-DM1 (T-DM1) in patients with advanced HER2+ breast cancer
Published in Cancer research (Chicago, Ill.) (15-01-2009)“…Abstract Abstract #3136 Background: T-DM1, a novel HER2 antibody-drug conjugate (ADC) in development for HER2+ breast cancer (BC), combines activity of…”
Get full text
Journal Article -
16
Competition in California: the new wave from the West
Published in Frontiers of health services management (01-05-1985)Get more information
Journal Article -
17
A phase I study of trastuzumab-MCC-DM1 (T-DM1), a first-in-class HER2 antibody-drug conjugate (ADC), in patients (pts) with HER2+ metastatic breast cancer (BC)
Published in Journal of clinical oncology (20-06-2007)“…Abstract only 1042 Background: ADCs utilize tumor-specific and/or over-expressed surface antigens that undergo internalization to deliver highly potent…”
Get full text
Journal Article -
18
A phase I study of weekly dosing of trastuzumab-DM1 (T-DM1) in patients (pts) with advanced HER2+ breast cancer (BC)
Published in Journal of clinical oncology (20-05-2008)“…Abstract only…”
Get full text
Journal Article -
19
A phase I study of trastuzumab-DM1 (T-DM1), a first-in-class HER2 antibody-drug conjugate (ADC), in patients (pts) with advanced HER2+ breast cancer (BC)
Published in Journal of clinical oncology (20-05-2008)“…Abstract only…”
Get full text
Journal Article -
20